These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33292658)

  • 1. Non-catecholamine vasopressors in the treatment of adult patients with septic shock-evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Zhong L; Ji XW; Wang HL; Zhao GM; Zhou Q; Xie B
    J Intensive Care; 2020 Oct; 8(1):83. PubMed ID: 33292658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis.
    Huang L; Zhang S; Chang W; Xia F; Liu S; Yang Y; Qiu H
    BMC Anesthesiol; 2020 Mar; 20(1):58. PubMed ID: 32138657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
    McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
    JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
    Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
    Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressors in septic shock: a systematic review and network meta-analysis.
    Zhou F; Mao Z; Zeng X; Kang H; Liu H; Pan L; Hou PC
    Ther Clin Risk Manag; 2015; 11():1047-59. PubMed ID: 26203253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
    Jia L; Wang P; Li C; Xie J
    Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis.
    Jiang L; Sheng Y; Feng X; Wu J
    Crit Care; 2019 Mar; 23(1):91. PubMed ID: 30871607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
    Al Sulaiman K; Alkofide HA; AlFaifi ME; Aljohani SS; Al Harthi AF; Alqahtani RA; Alanazi AM; Nazer LH; Al Shaya AI; Aljuhani O
    Saudi Pharm J; 2024 Jun; 32(6):102094. PubMed ID: 38812943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive Vasopressors in Patients with Septic Shock: Protocol for a Systematic Review and Meta-Analysis.
    Bauer SR; Wieruszewski PM; Bissell BD; Dugar S; Sacha GL; Sato R; Siuba MT; Schleicher M; Vachharajani V; Falck-Ytter Y; Morgan RL
    medRxiv; 2023 Jul; ():. PubMed ID: 37546921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis.
    Yao RQ; Xia DM; Wang LX; Wu GS; Zhu YB; Zhao HQ; Liu Q; Xia ZF; Ren C; Yao YM
    Front Pharmacol; 2020; 11():563. PubMed ID: 32435192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of effect of norepinephrine and terlipressin on patients with ARDS combined with septic shock: a prospective single-blind randomized controlled trial].
    Chen Z; Zhou P; Lu Y; Yang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):111-116. PubMed ID: 28625256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terlipressin for septic shock patients: a meta-analysis of randomized controlled study.
    Zhu Y; Huang H; Xi X; Du B
    J Intensive Care; 2019; 7():16. PubMed ID: 30923620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of pituitrin versus norepinephrine in the treatment of patients with septic shock].
    Han XD; Sun H; Huang XY; Zhang SY; Wang YD; Ren K; Li F
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jan; 24(1):33-7. PubMed ID: 22248749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials.
    Cheng L; Yan J; Han S; Chen Q; Chen M; Jiang H; Lu J
    Crit Care; 2019 May; 23(1):168. PubMed ID: 31088524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.